
Carbapenemase-producing Enterobacterales (CPE) are increasing nationwide, with harder-to-treat NDM strains reshaping the resistance landscape. In this Q&A, Lucas Schulz, PharmD, explains why rapid diagnostics and stewardship are critical to protecting patients and preserving last-line antibiotics.






















